Rhazinilam alkaloids are a class of natural compounds extracted from the plant Rhus coriaria, commonly known as the common sumac. These alkaloids have been found to possess various pharmacological activities. Rhazinilam derivatives exhibit potent anti-inflammatory effects, making them potential candidates for treating inflammatory diseases and conditions such as asthma and allergic reactions. Additionally, studies suggest that these compounds may also exert antimicrobial properties against certain bacteria, providing a promising avenue in the development of novel antibacterial agents. Moreover, some research indicates that Rhazinilam alkaloids could have antitumor activities, making them of interest for anticancer drug discovery. The structure and biological activity of these alkaloids make them valuable tools for both pharmacological studies and the exploration of new therapeutic strategies.